Baylor College of Medicine: Biological E. Limited to Begin Phase III Clinical Trials With Baylor and Texas Children's Vaccine
April 27, 2021
April 27, 2021
HOUSTON, Texas, April 27 (TNSOps) -- The Baylor College of Medicine issued the following news:
Biological E. Limited (BE), an Indian vaccine and pharmaceutical company, announced that it has completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization - Subject Expert Committee (SEC). The candidate includes an antigen developed by the Tex . . .
Biological E. Limited (BE), an Indian vaccine and pharmaceutical company, announced that it has completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization - Subject Expert Committee (SEC). The candidate includes an antigen developed by the Tex . . .